Physician profile
Abraham King Lin
NPI 1841388782
$7,385.28
in general payments reported to CMS, 2019-2025
36 companies · $1,007 in 2025
The $1,007 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2020: $199 · 2021: $1,143 · 2022: $1,477 · 2023: $1,223 · 2024: $1,231 · 2025: $1,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,434 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,434.30 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,470.30 | 2019-2025 | Aveir, Diamondback Peripheral, Assurity |
| Boston Scientific Corporation | $1,082.73 | 2019-2025 | Watchman Flx, Eluvia, Peripheral Rotalink Plus |
| Cardiovascular Systems INC. | $756.94 | 2019-2023 | Diamondback Peripheral |
| Medtronic, INC. | $440.21 | 2021-2024 | Nanocross Elite, In.Pact Admiral, Hawkone |
| Vital Connect, INC | $420.09 | 2022-2024 | Vitalpatch Rtm |
| Bard Peripheral Vascular, INC. | $380.58 | 2019-2022 | |
| Vasorum USA INC. | $340.87 | 2022-2024 | Celt Acd |
| E.R. Squibb & Sons, L.L.C. | $276.04 | 2019-2025 | Eliquis |
| Edwards Lifesciences Corporation | $243.29 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Philips North America LLC | $209.72 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Novartis Pharmaceuticals Corporation | $197.78 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $162.65 | 2019-2023 | Xarelto |
| Angiodynamics, INC. | $150.95 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Astrazeneca Pharmaceuticals Lp | $145.59 | 2020-2024 | Andexxa, Farxiga, Brilinta |
| Cvrx, INC. | $128.30 | 2024-2025 | Barostim Neo System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $128.16 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $122.52 | 2021-2025 | Verquvo, Winrevair |
| Atricure, INC. | $94.33 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.33 | 2021-2025 | Lifevest |
| Shockwave Medical, INC | $80.65 | 2025 | |
| Amgen INC. | $74.94 | 2019-2025 | Repatha, Repatha |
| Abiomed | $67.00 | 2025 | |
| Amarin Pharma, INC. | $58.38 | 2022 | |
| Irhythm Technologies, INC. | $31.97 | 2024 | Zio Xt Patch, Zio Monitor |
| Stryker Corporation | $29.12 | 2025 | Flowtriever |
| Pfizer INC. | $26.93 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $22.19 | 2021 | |
| Astellas Pharma US INC | $22.11 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $21.36 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $19.71 | 2024 | |
| Glaxosmithkline, LLC. | $17.69 | 2025 | Shingrix, Arexvy |
| Novo Nordisk INC | $17.39 | 2025 | Wegovy |
| Daiichi Sankyo INC. | $17.13 | 2023 | Injectafer |
| Penumbra, INC. | $17.00 | 2019 | |
| Baxter Healthcare | $13.81 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Biotronik INC. | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.